AI assistant
Sending…
Briscoe Group Limited — Director's Dealing 2022
Mar 27, 2022
66166_rns_2022-03-28_0afa47df-b936-4f43-a16c-c9f1d90699a1.pdf
Director's Dealing
Open in viewerOpens in your device viewer
==> picture [94 x 26] intentionally omitted <==
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
| To NZX Limited; and | |||
|---|---|---|---|
| Name of listed issuer: | Briscoe GroupLimited | ||
| Date this disclosure made: | 28/03/2022 | ||
| Date of last disclosure: | 18/03/2022 | ||
| Director or senior managergiving disclosure | |||
| Full name(s): | GeoffreyPeterScowcroft | ||
| Name of listed issuer: | Briscoe GroupLimited | ||
| Name of related body corporate (if applicable): | N/A | ||
| Position held in listed issuer: | Chief FinancialOfficer | ||
| Summary of acquisition or disposal of relevant interest (excluding specified derivatives) | |||
| Class of affected quoted financial products: | Ordinary shares | ||
| Nature of the affected relevant interest(s): | Beneficial interest as owner | ||
| For that relevant interest- | |||
| Number held in class before acquisition or disposal: | 303,061 | ||
| Number held in class after acquisition or disposal: | 296,321 | ||
| Current registered holder(s): | GeoffreyPeterScowcroft | ||
| Registered holder(s)once transfers are registered: | GeoffreyPeterScowcroft | ||
| Summary of acquisition or disposal of specified derivatives relevant interest (if applicable) | |||
| Type of affected derivative: | N/A | ||
| Class of underlyingfinancialproducts: | N/A | ||
| Details of affected derivative- | |||
| The notional value of the derivative (if any) or the notional amount of underlying financial | |||
| products(if any): | N/A | ||
| A statement as to whether the derivative is cash settled orphysicallysettled: | N/A | ||
| Maturitydate of the derivative(if any): | N/A | ||
| Expirydate of the derivative(if any): | N/A | ||
| Theprice specified in the terms of the derivative(if any): | N/A | ||
| Any other details needed to understand how the amount of the consideration payable | |||
| under the derivative or the value of the derivative is affected by the value of the | |||
| underlying financial products: | N/A | ||
| _For that derivative,- _ | |||
| Parties to the derivative: | N/A | ||
| If the director or senior manager is not a party to the derivative, the nature of the relevant | |||
| interest in the derivative: | N/A | ||
| Details of transactions giving rise to acquisition or disposal | |||
| Total numberoftransactions towhich noticerelates: | 25 | ||
| Details of transactions requiring disclosure- | |||
| Date oftransaction: | 22/03/2022, | 23/03/2022 | |
| Nature of transaction: | Sale of Ordinary shares on market | ||
| Name of anyotherpartyorparties to the transaction(if known): | N/A | ||
| The consideration, expressed in New Zealand dollars, paid or received for the acquisition | |||
| or disposal. If the consideration was not in cash and cannot be readily by converted into a | |||
| cash value,describe the consideration: | $40,619.17 | ||
| Numberof financialproducts towhichthe transaction related: | 6,740 |
| If the issuer has a financial products trading policy that prohibits directors or seniormanagers from trading during any period without written clearance (a closed period)include the following details— | NoN/AN/A1. Ordinary Shares2. Performance rights1. Non-beneficial interest as director ofManhattan Trustee Limited andbeneficial interest as beneficiary of theManhattan Trust2. Contingent beneficial owner (asholder of performance rights under theBriscoe Group Senior ExecutiveIncentive Plan)1. 683,0002. 49,5951. Manhattan Trustee Limited2. Geoffrey Peter ScowcroftN/A | NoN/AN/A1. Ordinary Shares2. Performance rights1. Non-beneficial interest as director ofManhattan Trustee Limited andbeneficial interest as beneficiary of theManhattan Trust2. Contingent beneficial owner (asholder of performance rights under theBriscoe Group Senior ExecutiveIncentive Plan)1. 683,0002. 49,5951. Manhattan Trustee Limited2. Geoffrey Peter ScowcroftN/A | |
|---|---|---|---|
| Whether relevantinterestswere acquired ordisposed ofduring a closed period: | No | ||
| Whether prior written clearance was provided to allow the acquisition or disposal toproceed duringthe closedperiod: | N/A | ||
| Date of theprior written clearance(if any): | N/A | ||
| Summary of other relevant interests after acquisition or disposal:Class of quoted financial products:Nature of relevant interests:_For each relevant interest,- _Number held in class:Current registered holder(s):For a derivative relevant interest,-Type ofderivative:Details of derivative,- | |||
| The notional value of the derivative (if any) or the notional amount of underlying financialproducts (if any): | N/A | ||
| A statement as to whether the derivative is cash settled or physically settled: | N/A | ||
| Maturity date of the derivative (if any): | N/A | ||
| Expiry date of the derivative (if any): | N/A | ||
| The price's specified terms (if any): | N/A | ||
| Any other details needed to understand how the amount of the consideration payableunder the derivative or the value of the derivative is affected by the value of theunderlyingfinancialproducts: | N/A | ||
| For that derivative relevant interest,- | |||
| Parties to the derivative: | N/A | ||
| If the director or senior manager is not a party to the derivative, the nature of the relevantinterest in the derivative: | N/A | ||
| CertificationI certify that, to the best of my knowledge and belief, the information contained in thisdisclosure is correct and that I am duly authorised to make this disclosure by all personsfor whom it is made.Signature of director or officer:Date of signature:orSignature of person authorised to sign on behalf of director or officer:Date of signature:Name and title of authorisedperson: | 28/03/2022 | ||
| Signature of person authorised to sign on behalf of director or officer: | |||
| Date of signature: | |||
| Name and title of authorisedperson: | |||
| NotesUse this form to disclose all the acquisitions and disposals by a director or seniormanager of a listed issuer, or of a related body corporate, or in specified derivatives. Thedisclosure must be made within—(a) 20 working days after the first acquisition or disposal disclosed in thisnotice if the acquisitions or disposals are of a kind referred to in section 297(2)(a) of theFinancial Markets Conduct Act 2013; or(b) in any other case, 5 trading days after the first acquisition or disposaldisclosed in this notice. | |||
More from Briscoe Group Limited
Declaration of Voting Results & Voting Rights Announcements
2026
May 7
AGM Information
2026
May 6
Capital/Financing Update
2026
Apr 30
AGM Information
2026
Apr 1
Regulatory Filings
2026
Apr 1
Regulatory Filings
2026
Mar 15
Regulatory Filings
2026
Mar 12
Earnings Release
2026
Mar 10
Regulatory Filings
2026
Mar 5
Board/Management Information
2026
Mar 1